Your institution may have access to this item. Find your institution then sign in to continue.
Title
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.
Authors
Keitel, Wendy A; Campbell, James D; Treanor, John J; Walter, Emmanuel B; Patel, Shital M; He, Fenhua; Noah, Diana L; Hill, Heather
Abstract
Dose-sparing strategies are being explored for vaccines against pandemic influenza. We evaluated the dose-sparing potential of aluminum hydroxide (AlOH) adjuvant.
Publication
The Journal of infectious diseases, 2008, Vol 198, Issue 9, p1309